Mahoney demonstrates a complex leadership style that transformed Boston Scientific from an overly conservative culture to a more dynamic organization, though his persistence with the Lotus program despite manufacturing challenges suggests a potential blind spot in decision-making when emotionally invested in clinical outcomes.